受强制性开放获取政策约束的文章 - Mamta Gupta, Ph.D (Associate Professor)了解详情
无法在其他位置公开访问的文章：1 篇
Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach
K Le, J Vollenweider, JJ Han, N Staudinger, M Stenson, L Bayraktar, ...
Hematological oncology 42 (1), e3233, 2024
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：28 篇
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
TE Witzig, CB Reeder, BR LaPlant, M Gupta, PB Johnston, IN Micallef, ...
Leukemia 25 (2), 341-347, 2011
强制性开放获取政策： US National Institutes of Health
Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation
M Gupta, JJ Han, M Stenson, M Maurer, L Wellik, G Hu, S Ziesmer, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2844-2853, 2012
强制性开放获取政策： US National Institutes of Health
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
SM Ansell, H Tang, PJ Kurtin, PA Koenig, DJ Inwards, K Shah, ...
The lancet oncology 12 (4), 361-368, 2011
强制性开放获取政策： US National Institutes of Health
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
M Gupta, SM Ansell, AJ Novak, S Kumar, SH Kaufmann, TE Witzig
Blood, The Journal of the American Society of Hematology 114 (14), 2926-2935, 2009
强制性开放获取政策： US National Institutes of Health
The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation
G Hu, Z Lou, M Gupta
PloS one 9 (9), e107016, 2014
强制性开放获取政策： US National Institutes of Health
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy
M Gupta, JJ Han, M Stenson, L Wellik, TE Witzig
Leukemia 26 (6), 1356-1364, 2012
强制性开放获取政策： US National Institutes of Health
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
TE Witzig, C Reeder, JJ Han, B LaPlant, M Stenson, HW Tun, W Macon, ...
Blood, The Journal of the American Society of Hematology 126 (3), 328-335, 2015
强制性开放获取政策： US National Institutes of Health
Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies
M Gupta, AEW Hendrickson, SS Yun, JJ Han, PA Schneider, BD Koh, ...
Blood, The Journal of the American Society of Hematology 119 (2), 476-487, 2012
强制性开放获取政策： US National Institutes of Health
Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma
MJ Maurer, INM Micallef, JR Cerhan, JA Katzmann, BK Link, JP Colgan, ...
Journal of clinical oncology 29 (12), 1620-1626, 2011
强制性开放获取政策： US National Institutes of Health
Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP
M Gupta, MJ Maurer, LE Wellik, ME Law, JJ Han, N Ozsan, IN Micallef, ...
Blood, The Journal of the American Society of Hematology 120 (22), 4400-4406, 2012
强制性开放获取政策： US National Institutes of Health
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth
SM Ansell, T Akasaka, E McPhail, M Manske, E Braggio, T Price-Troska, ...
Blood, The Journal of the American Society of Hematology 120 (19), 3949-3957, 2012
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase–regulated mammalian target of …
M Gupta, SR Dillon, SC Ziesmer, AL Feldman, TE Witzig, SM Ansell, ...
Blood, The Journal of the American Society of Hematology 113 (21), 5206-5216, 2009
强制性开放获取政策： US National Institutes of Health
Signal transduction inhibitor therapy for lymphoma
TE Witzig, M Gupta
Hematology 2010, the American Society of Hematology Education Program Book …, 2010
强制性开放获取政策： US National Institutes of Health
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
TE Witzig, H Tang, INM Micallef, SM Ansell, BK Link, DJ Inwards, ...
Blood, The Journal of the American Society of Hematology 118 (18), 4882-4889, 2011
强制性开放获取政策： US National Institutes of Health
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B‐cell non‐Hodgkin …
TE Witzig, GA Wiseman, MJ Maurer, TM Habermann, INM Micallef, ...
American journal of hematology 88 (7), 589-593, 2013
强制性开放获取政策： US National Institutes of Health
A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling
G Hu, TE Witzig, M Gupta
PloS one 8 (7), e67851, 2013
强制性开放获取政策： US National Institutes of Health
Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy
TE Witzig, G Hu, SM Offer, LE Wellik, JJ Han, MJ Stenson, A Dogan, ...
Leukemia 28 (1), 147-154, 2014
强制性开放获取政策： US National Institutes of Health
Elevated soluble IL‐2 R α, IL‐8, and MIP‐1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma
MB Sonbol, MJ Maurer, MJ Stenson, C Allmer, BR LaPlant, GJ Weiner, ...
American journal of hematology 89 (12), E223-E227, 2014
强制性开放获取政策： US National Institutes of Health
Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma
C Demosthenous, JJ Han, MJ Stenson, MJ Maurer, LE Wellik, B Link, ...
Oncotarget 6 (11), 9488, 2015
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定